ProveIt Supplements

Independent, evidence-based supplement analysis.

✓ Not Sponsored

✓ No Paid Reviews

✓ Science-Based

Company

  • About Us
  • Our Methodology
  • Contact
  • Blog
  • Authors

Legal

  • Privacy Policy
  • Terms of Service
  • Medical Disclaimer
  • Affiliate Disclosure

Resources

  • All Categories
  • Ingredient Database
  • Browse Supplements
  • FAQ

© 2025 ProveIt Supplements. All rights reserved.

Medical Disclaimer: The information provided is for educational purposes only and is not intended as medical advice. Always consult with a qualified healthcare professional before starting any supplement regimen.

Prove It
Browse SupplementsBlogAuthorsAboutMethodologyFAQ
Get Your Personalized Supplement StackSupplement Stack Quiz
Menu
HomeBrowse SupplementsBlogAuthorsAboutMethodologyFAQ
Back

Grifola Frondosus

Also known as: Maitake mushroom, Hen-of-the-woods, Medicinal mushroom supplement, fungal polysaccharide extract, Grifola frondosa

Overview

Grifola frondosa, commonly known as Maitake mushroom or Hen-of-the-woods, is a polypore mushroom indigenous to northeastern Japan and North America. It has a long history of use in East Asian traditional medicine and is widely consumed as a dietary supplement. The primary interest in Maitake stems from its purported immunomodulatory, antitumor, and metabolic health benefits. These effects are largely attributed to its key bioactive components, particularly beta-glucan polysaccharides. While there is a substantial body of preclinical research and some clinical trials supporting its potential, high-quality human randomized controlled trials (RCTs) are still limited. Systematic reviews and meta-analyses primarily highlight its preclinical antitumor effects and observational associations with a reduced risk of certain cancers. Maitake is available in various forms, including powders, extracts, and capsules, and is generally considered safe for consumption.

Benefits

Maitake mushroom offers several potential health benefits, primarily due to its rich content of beta-glucan polysaccharides: - **Antitumor effects:** Preclinical studies, including a 2021 meta-analysis of in vivo animal studies, have demonstrated significant tumor growth inhibition by *G. frondosa* polysaccharides. This suggests potential antineoplastic activity through mechanisms involving immunomodulation and direct tumor suppression. However, robust clinical trials in humans are currently sparse and inconclusive, meaning these findings have not been definitively translated to human cancer treatment. - **Cancer risk reduction:** A systematic review and meta-analysis of observational studies indicated an association between higher mushroom consumption, including *G. frondosa*, and a statistically significant lower risk of various cancers. While this suggests a protective effect, it's important to note that observational studies cannot establish causality, and other lifestyle factors may contribute. - **Metabolic effects:** Preliminary evidence from small clinical and animal studies suggests that *G. frondosa* extracts may improve glucose metabolism and insulin sensitivity, potentially offering benefits for individuals with type 2 diabetes. Studies have shown improvements in glucose tolerance and reduced glucosuria in diabetic rat models, along with some preliminary human data indicating hypoglycemic effects. More research is needed to confirm these findings in larger human populations. - **Cholesterol lowering:** Animal studies have indicated that Maitake fiber may contribute to reducing cholesterol levels. However, human data supporting this benefit are limited and require further confirmation through well-designed clinical trials.

How it works

The primary mechanism of action for *Grifola frondosa* is attributed to its beta-glucan polysaccharides. These compounds interact with and activate various immune cells, including macrophages, natural killer (NK) cells, and T lymphocytes, thereby enhancing both innate and adaptive immune responses. This activation can lead to the increased production of cytokines, such as interleukins and tumor necrosis factor-alpha (TNF-α), which play crucial roles in the body's immune defense and antitumor immunity. While the oral bioavailability of beta-glucans is limited, they appear to exert systemic effects through the activation of gut-associated lymphoid tissue (GALT). For its metabolic effects, *G. frondosa* may modulate insulin signaling pathways and glucose uptake, although the precise molecular targets and mechanisms are still under investigation.

Side effects

Overall, *Grifola frondosa* supplements are considered safe for consumption and are associated with a low incidence of adverse effects. Common side effects, occurring in more than 5% of users, are not well documented but may include mild gastrointestinal discomfort, such as bloating or indigestion. Rare allergic reactions have been reported, particularly in individuals with known sensitivities or allergies to mushrooms. While no significant drug interactions or contraindications are firmly established, caution is advised for certain populations. Due to its immunostimulatory properties, individuals who are immunocompromised or those taking immunosuppressant medications should consult a healthcare provider before using Maitake supplements. There is also a theoretical concern for individuals on anticoagulant medications due to potential effects on platelet aggregation, though this is not well-substantiated in human studies. Pregnant or breastfeeding women should also exercise caution due to a lack of sufficient safety data.

Dosage

Clinical dosing for *Grifola frondosa* varies considerably across studies, and an optimal dosage for specific indications has not been definitively established due to the limited number of large-scale randomized controlled trials. Typically, studies utilize Maitake polysaccharide extracts standardized to beta-glucan content, with common dosages ranging from 1 to 6 grams per day. The form of the supplement (e.g., powder, extract, capsule) and the timing of administration may influence bioavailability and efficacy, but standardized guidelines are not yet available. For general immune support, lower doses within this range might be used, while higher doses have been explored in preclinical cancer research. There are no established upper limits or safety thresholds, but adherence to product-specific recommendations is advised. Co-administration with other immunomodulatory agents has not been systematically studied, and caution is advised.

FAQs

Is Maitake effective for cancer treatment?

Preclinical evidence from animal studies supports the antitumor activity of Maitake polysaccharides, showing tumor growth inhibition. However, robust clinical trials in humans are currently lacking, so it is not a proven cancer treatment.

Can Maitake help with diabetes?

Preliminary animal and small human studies suggest that Maitake extracts may improve glucose metabolism and insulin sensitivity. While promising, more extensive research is needed to confirm these benefits for diabetes management.

Is Maitake safe to take daily?

Maitake is generally considered safe for daily consumption with a low incidence of side effects. However, individuals with mushroom allergies, autoimmune conditions, or those on immunosuppressants should consult a healthcare provider before use.

How long before effects appear?

Animal studies have shown effects within weeks of Maitake administration. For humans, there is insufficient data to specify a precise timeframe for when benefits might become noticeable, as it can vary by individual and condition.

Research Sources

  • https://pubmed.ncbi.nlm.nih.gov/34271115/ – This meta-analysis of in vivo animal studies investigated the antitumor effects of Maitake polysaccharides. It found significant tumor growth inhibition, suggesting potential antineoplastic activity, but highlighted the need for human clinical trials due to the preclinical nature of the evidence.
  • https://pmc.ncbi.nlm.nih.gov/articles/PMC8483951/ – This systematic review and meta-analysis examined the association between mushroom consumption and cancer risk. It concluded that higher mushroom intake, including *G. frondosa*, was associated with a statistically significant lower risk of various cancers, though it noted the limitations of observational study designs in establishing causality.
  • https://www.liebertpub.com/doi/full/10.1089/acm.2009.0696?src=recsys – This source, likely related to Manohar et al. (2002) and subsequent studies, discusses the metabolic effects of Maitake. It points to preliminary evidence from small animal and human studies suggesting improvements in glucose tolerance and insulin sensitivity, indicating potential benefits for metabolic health, though further research is needed.

Supplements Containing Grifola Frondosus

UltraImmune9 by Get Healthy Again
78

UltraImmune9

Get Healthy Again

Score: 78/100